CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,193,310
- in 2 filings, $1.2M under 10b5-1 plans
Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-13 | FMR LLC 10% owner | Sale | −6,799 | $50.70 | $345K | 12,004 |
| 2022-04-13 | FMR LLC 10% owner | Sale | −8,804 | $50.01 | $440K | 3,200 |
| 2022-04-13 | FMR LLC 10% owner | Sale | −3,200 | $50.80 | $163K | 0 |
| 2022-04-12 | FMR LLC 10% owner | Other disposition | −978,503 | 2,935,511 | ||
| 2022-04-12 | FMR LLC 10% owner | Other acquisition | +509,490 | 509,995 | ||
| 2022-04-12 | FMR LLC 10% owner | Other disposition | −509,332 | 663 | ||
| 2022-04-12 | FMR LLC 10% owner | Other acquisition | +137,845 | 141,151 | ||
| 2022-04-12 | FMR LLC 10% owner | Other disposition | −128,333 | 12,818 | ||
| 2022-04-12 | FMR LLC 10% owner | Other acquisition | +15,406 | 18,803 | ||
| 2022-04-12 | FMR LLC 10% owner | Other acquisition | +422,120 | 2,490,515 | ||
| 2022-03-31 | Ciaramella Giuseppe President & CSO | Grant or award | +15,000 | 117,473 | ||
| 2022-03-31 | Ciaramella Giuseppe President & CSO | Sale | −1,859 | $59.11 | $110K | 115,614 |
| 2022-03-31 | Evans John M. CEO | Grant or award | +56,250 | 1,095,331 | ||
| 2022-03-31 | Evans John M. CEO | Sale | −6,261 | $59.11 | $370K | 1,089,070 |
| 2022-03-31 | Burrell Terry-Ann CFO | Grant or award | +15,000 | 40,065 | ||
| 2022-03-31 | Burrell Terry-Ann CFO | Sale | −1,787 | $59.11 | $106K | 38,278 |
| 2022-01-31 | Ciaramella Giuseppe President & CSO | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-01-31 | Evans John M. CEO | Sale | −801 | $63.79 | $51K | 968,024 |
| 2022-01-31 | Evans John M. CEO | Sale | −2,172 | $64.47 | $140K | 965,852 |
| 2022-01-31 | Evans John M. CEO | Sale | −3,177 | $65.49 | $208K | 962,675 |
Page 17 of 32 · 630 trades